US Stock Market Move | Vaccine concept stocks rise and fall differently. Novavax, Inc. (NVAX.US) rose more than 5.4%.
As of the time of publication, the stock has risen by more than 5.4%, reaching $12.57.
On Friday, vaccine concept stocks fluctuated, with Novavax, Inc. (NVAX.US) rising, reaching a high of over 5.4% to $12.57 per share at the time of writing. The company announced that their updated COVID-19 vaccine has been approved for use in the United States for individuals aged 12 and above.
Moderna (MRNA.US) decreased by nearly 4% to $66.92 per share. Moderna plans to launch a skin cancer vaccine based on mRNA as early as next year. It was reported that Moderna has released mid-term data on their individualized cancer vaccine named mRNA-4157, which is being used in combination with Merck & Co., Inc.'s (MRK.US) PD-1 therapy Keytruda for the treatment of melanoma. Pfizer Inc. (PFE.US) also saw a slight decrease of 0.22%.
Related Articles
Sedge Pharmaceuticals (688266.SH): Injection ZG006 conducted a crucial clinical trial and completed the enrollment of the first subject.
HK Stock Market Move | CHERVON(02285) rose by more than 6%. Institutions are optimistic about its long-term benefits from the repair of the American real estate market.
.png)
Jack Ma "strongly returns" to lead Alibaba (09988) in the AI and food delivery battle.
Sedge Pharmaceuticals (688266.SH): Injection ZG006 conducted a crucial clinical trial and completed the enrollment of the first subject.
HK Stock Market Move | CHERVON(02285) rose by more than 6%. Institutions are optimistic about its long-term benefits from the repair of the American real estate market.
Jack Ma "strongly returns" to lead Alibaba (09988) in the AI and food delivery battle.
